ReCode Therapeutics has raised over $29 million in additional financing to advance its genetic medicines pipeline, supported by $3 million from the Cystic Fibrosis Foundation.
Amount Raised
$29 Million
Round Type
Funding Round
Menlo ParkBiotechnologyHealthcareHealth CareInvestors
Description
ReCode Therapeutics, a clinical-stage genetic medicines company, announced the close of over $29 million in additional financing. The funding will accelerate the development of inhaled mRNA therapy for cystic fibrosis. The company also reported expanded support from the Cystic Fibrosis Foundation and a new collaboration with Praxis Precision Medicines. This funding aims to enhance treatment options for genetic diseases.
Quick answer
ReCode Therapeutics raised $29 Million in a Funding Round round, dated September 29, 2025. Investors: Praxis Precision Medicines and Cystic Fibrosis Foundation. ReCode Therapeutics is based in Menlo Park, California, United States.
- How much did ReCode Therapeutics raise?
- ReCode Therapeutics raised $29 Million in a Funding Round round on September 29, 2025.
- Who invested in ReCode Therapeutics?
- Praxis Precision Medicines and Cystic Fibrosis Foundation are named as investors in this round.
- What does ReCode Therapeutics do?
- ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
- Where is ReCode Therapeutics based and how big is it?
- ReCode Therapeutics is based in Menlo Park, California, United States.
- Who are the decision-makers at ReCode Therapeutics?
- Fundz holds 1 contact at ReCode Therapeutics, including the Head of Clinical Operations | Rare Diseases. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as ReCode Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Nanoviricides raised $6M on November 12, 2025.
- Damora Therapeutics, Inc. raised $285M on November 12, 2025.
- Tenon Medical raised $2.9M (Funding Round) on November 11, 2025.
- Allurion Technologies raised $5M (Private Equity) on November 11, 2025.
- Reimagine Care raised $2.4M on November 10, 2025.
- Pelthos Therapeutics raised $18M on November 6, 2025.
Who to call at ReCode Therapeutics, and when
A new round usually means ReCode Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ReCode Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ReCode Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReCode Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ReCode Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.